ArticlePathology oncology research : POR2019

Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell Lymphoma.

Ghada Mohamed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.